Diverse leaders to identify emerging innovators


IDEA2 Madrid Co-Chairs

Rocío Anula
Hospital Clínico San Carlos

Ignacio Navarro Arrate
Siemens Healthcare Spain

Javier Colas
Medtronic

Eduardo Díaz
Fundación para el Conocimiento madri+d

Roberto García-Álvarez
GE Healthcare

Ángel Lanuza
Fenin

María Luaces Méndez
Hospital Clínico San Carlos

Norberto Malpica
Universidad Rey Juan Carlos
Associate Director, Madrid-MIT M+Visión Consortium

Mario Martínez-Galdámez
Hospital Clínico San Carlos

Julio Mayol
Hospital Clínico San Carlos
Co-director, Madrid-MIT M+Visión Consortium

Ricardo Ruiz de España
MSD

Rafael Coronado-Santos
Siemens Healthcare Spain

Juan Antonio Hernández Tamames
Universidad Rey Juan Carlos

Rocío Anula
Hospital Clínico San Carlos

Dr Anula currently works as a digestive surgeon in the Division of Colorectal Surgery at the Hospital Clínico San Carlos. She also collaborates as a volunteer professor of surgery at the Complutense University of Madrid. She graduated from the Complutense University Medical Schoo, completed her residency program in general surgery at the Department of Surgery of San Carlos Clinic Hospital in Madrid, and obtained a Doctoral Degree summa cum laude from Complutense University. She has also participated as a visiting medical doctor in the Division of Colorectal Surgery at University of California San Francisco. She is a member of the Spanish Society of Surgeons, as well as a member of the Society of Surgery of the Alimentary Tract and the Spanish Society of Surgical Research. At present, besides her regular activity at the hospital focused in the management of colorectal cancer patients and inflammatory bowel disease, she is extremely interested in image-guided surgery, and collaborates with activities related to it.

Ignacio Navarro Arrate
Siemens

Mr Navarro Arrate has been working for Siemens for almost 10 years as a Commercial Project Manager in the Healthcare sector. He has a degree in business management and administration from the San Pablo CEU University and a Master’s in health technology and management from the University of Alcalá in Madrid, Spain. Mr Navarro Arrate has received various awards in the field of technological innovation in healthcare, including being selected from a large number of candidates worldwide to participate in a three-month “Innovation Think Tank” organized by Siemens Healthcare Germany. For his efforts in that program, he won the “Young Innovator Award” and came second in the “Most Innovative Project of the Program”. More recently, his project, an adaptable table for radiotherapy patients called ADAPTABLE, was one of the winners of the first IDEA2 Madrid. At present, Mr Navarro Arrate is involved in the creation and development of a number of cutting-edge projects. He is often invited to speak on “Creativity, Innovation and the Attractive Presentation of Ideas” as a guest lecturer at the Postgraduate School of the University of Alcalá.

Javier Colas
Medtronic

Javier Colás is President of Medtronic in Spain and Portugal, and Corporate Vice-president of the company. Medtronic is a multinational company, and a leader in the field of Therapeutic Healthcare Technology, employing nearly 45.000 people in 120 countries. His education in telecommunications engineering and medicine inform his a strategic vision for driving the development of new technologies. Javier is Vice President of FENIN, the Spanish Federation of Healthcare Technology companies, and President of the Fundación Tecnología y Salud (Technology and Healthcare Foundation), a foundation it supports. He is a member of the Spanish Society of Cardiology, the Spanish Advisory Board of Casa del Corazón, and the Engineering in Medicine and Biology Society of IEEE. He is also a member of the US-Spain Council and the American Chamber of Commerce. He belongs to the board of several medical technology industries such as Health-In-Code, Weartech, and Wake App Health. He has participated in numerous conferences and publications on healthcare technology and clinical management.

Eduardo Díaz
Fundación Para el Conocimiento madri+d

Eduardo Díaz is currently in charge of the New Technology-Based Firms Unit at Fundación para el Conocimiento madri+d. He manages regional, national and international programs in the fields of entrepreneurship, startup funding, venture mentoring and R&D commercialization. Expert in the fields of startups, innovation, regional development, technology auditing, technology transfer and cluster policies, he has held the positions of Innovation Manager Consultant at Socintec, University Lecturer, Project Controller, and Software Engineer in the electronics and aerospace sectors (Indra, Epel). He has also coordinated multiple studies and publications in the fields of innovation and technology-based entrepreneurship.

Roberto García-Álvarez
GE Healthcare

Dr García-Álvarez currently works as a Magnetic Resonance (MR) Clinical Scientist at GE Healthcare. In his current role, Roberto engages in both product development and MR research collaborations across Southern Europe. Dr García-Álvarez earned a first class degree in physics with medical technology from the University of Hull, England, in 2002. In the following years he combined his PhD research work with a research assistance position at the Centre for Magnetic Resonance Technology at Hull Royal Infirmary, England. In 2006, he earned a PhD in medical physics from the same university. Roberto has held various academic and industry positions including: Undergraduate Research Fellowship at Imperial College of Science Technology and Medicine, Postgraduate Research Assistant at the University of Hull, MR Advanced Application in GE Healthcare and MVS specialist at INSA-IBM. He has proofread and provided illustration data to various MR books: MRI from A to Z – Cambridge University Press-1st edition, MR in clinical practice- Springer – 1st edition and MRI from A to Z –Springer – 2nd edition. Roberto is also an associate editor of Medical Physics, AAPM.

Ángel Lanuza
FENIN

Ángel has a degree in industrial engineering with honors from the University of Zaragoza; and a Master’s in quality and environmental management from the Institute of Company Directors IDE-CESEM. Mr Lanuza has been Coordinator of the Spanish Platform for Innovation in Technology Healthcare and Medical Technology for Fenin since 2010. He also works with the Corporación Sanitària Parc Taulí (CSPT) to develop different projects involving technological innovation in healthcare. His work focuses on the development, implementation, and acceleration of organizational innovation – the building and leading of successful, creative and innovative organizational cultures. In his many engagements, he aims to help companies with interests in the field of medical technology grow, focusing on using innovation and insight to accelerate and support such business growth.

María Luaces Méndez
Hospital Clinico San Carlos

Dr Luaces is a cum laude graduate of Santiago de Compostela Medical School. She completed cardiology residency training at Hospital Clínico San Carlos, developing an intense clinical research in infectious endocarditis that led to her PhD at Universidad Complutense de Madrid. She specialized in cardiac imaging, including a fellowship in cardiovascular CT and MRI at the Hospital of the University of Pennsylvania. She is the Director of the Clinical Research Program in Medical Imaging and Coordinator of the Medicine 2.0 Task Force at Hospital Universitario de Fuenlabrada. Her research interests are focused on obesity-related heart damage, with several funded ongoing projects including a comprehensive network of local institutions- Universidad Complutense de Madrid, Universidad Autónoma de Madrid, Universidad Rey Juan Carlos de Madrid, Universidad Politécnica de Madrid. She serves on the Editorial Board of several scientific journals and is a member of the European Society of Cardiology.

Norberto Malpica
Universidad Rey Juan Carlos
M+Visión Associate Director

Norberto Malpica is an associate professor at Universidad Rey Juan Carlos in Madrid. Norberto received a Master’s in telecommunication engineering from Universidad Politécnica de Madrid. After working for three years in the design and deployment of teleradiology systems, he earned a PhD in medical imaging from Universidad Politécnica de Madrid in 2004. He was a post-doctoral researcher at Hospital Universitario Gregorio Marañon in Madrid, before joining Universidad Rey Juan Carlos. He is currently the Director of the Master’s Program in Computer Vision at URJC, and a member of the madri+d Medical Image Analysis Lab and the Neuroimaging Lab at the Alzheimer’s Centre in Madrid.

Mario Martínez-Galdámez 
Fundacion Jimenez-Diaz & Hospital Rey Juan Carlos; Grupo Quiron-salud, Madrid

Dr Martínez-Galdámez currently serves as Director of the Interventional Neuroradiology Units at Fundacion Jimenez Diaz and Hospital Rey Juan Carlos, Madrid. He earned his medical degree from the Universidad Complutense de Madrid–UCM, followed by a radiology residency at the Hospital Universitario Puerta de Hierro de Madrid. He went on to train in neuroradiology and interventional neuroradiology at Fundación Jiménez Díaz-Madrid, then he served as Director of Interventional Neuroradiology at Hospital Clinico Universitario-Valladolid. Dr Martínez-Galdámez has contributed to international publications and clinical research projects for endovascular treatments of cerebral aneurysms, arteriovenous malformations and stroke.

Dr Martínez-Galdámez is an active lecturer and serves as a reviewer for several scientific journals including European Radiology and the Journal of Neurointerventional Surgery. Dr Martínez-Galdámez joined the Madrid-MIT M+Visión Consortium Faculty, and the Fellowship in Translational Biomedical Imaging’s evaluation committee, in 2013. He was certified by the Educational Commission for Foreign Medical Graduates (ECFMG).

Julio Mayol
Hospital Clínico San Carlos
M+Visión Co-Director

 

Dr Mayol currently serves as Director of the Innovation Unit at Hospital Clínico San Carlos Madrid, where he is also Chief of General Surgery. He works as a Professor of Surgery at Universidad Complutense University de Madrid, and a visiting professor in the Department of Surgery at Wayne State University in Detroit, MI. Dr Mayol graduated with honors and Doctoral Degree summa cum laude from Universidad Complutense de Madrid. He
has a Master’s in healthcare management from Universidad Complutense. From 1996 to 1997, Julio was a
research Fellow in Surgery at Harvard Medical School – Beth Israel Hospital. At present, he is the Chief of the Division of Coloretal Surgery at Hospital Clínico San Carlos and Chief Innovation Officer at Hospital Clínico San Carlos. He is member of the International Campus of Excellence Moncloa Advisory Committee (UCM-UPM) and corresponding Academics of the Royal Academy of Medicine. He founded the iSURGITEC consortium (International Surgical Group for innovation and Technology) formed by the departments of surgery at the University of Chicago Hospital Henry Ford Hospital Virgen del Rocío, Sevilla and Hospital Clínico San Carlos along with the Smart Sensors and Integrated Microsystems Institute of Wayne State University. Dr Mayol became Co-Director of the M+Visión Consortium in 2012.

Ricardo Ruiz de España
MSD

Ricardo’s 20 years of experience as manager in the Pharmaceutical Industry, and 7 years of experience as an entrepreneur- give him a deep understanding of the healthcare market. Currently, Ricardo is Merck’s Associate Sales Director and the founder of two companies, Tressoles and Innosuns. Tressoles is focused on developing innovative solutions in textiles. Innosuns targets innovative companies in healthcare. The company specializes in the impact plan of the idea, designing training activities required for the development of the project, and especially getting new avenues of funding compatible with traditional schemes for developing high value-added projects. Ricardo graduated in pharmacy from the Universidad Complutense de Madrid. He also holds an MBA, with the highest honors, from ICADE, the prestigious Spanish Business School. He completed postgraduate studies in Management of Technological Innovation at the Polytechnic University of Madrid (CEPADE). His career in began in a consulting firm, then developed at several pharmaceutical companies like Janssen- Cilag (J&J), Schering-Plough.

Rafael Coronado-Santos
Siemens Healthcare Spain

Dr Coronado currently serves as Collaboration Manager for the Imaging & Therapy and Clinical Products Divisions at SIEMENS Healthcare Spain. He is also a permanent member of the Executive Committee of the Imaging & Therapy Division. Dr Coronado graduated with a Master’s of engineering telecommunications from Seville University. He also holds an MSc in biomedical engineering, a Diploma from Imperial College London, and a PhD from Seville University. Throughout his career, he has lent his talents to various public institutions, companies, and sectors. His expertise ranges from IT Technologies and SW to solar power and bioengineering. He is a founding member of the Física Interdisciplinar (GFI) Research Group of Seville University (www.etsi.us.es/gfi). He collaborates in the GFI’s main research lines such as non-invasive surgery, applied neuro-surgery, neuroscience, and computer-aided diagnostic systems. Dr Coronado became member of the Executive Committee of IDEA2 Madrid in 2012.

Juan Antonio Hernández Tamames
Universidad Rey Juan Carlos

Juan Antonio Hernández Tamames is an MR Physicist and Associate Professor at Rey Juan Carlos University in Madrid. He is the director of the “Medical Image Analysis Lab” of the Neuroimaging Unit at Fundación CIEN – Fundación Reina Sofía (Alzheimer Project) and the founder of the “Medical Image Analysis lab” of madri+d. These labs are currently supporting several research studies and clinical trials for hospitals and research centers in
Madrid, mainly focused on Alzheimer’s disease, normal ageing, neurological impairments, and mental disorders. His
main research interests are focused on new quantitative biomarkers, or combinations of them, based on magnetic
resonance neuroimaging, for the study of different brain pathologies and normal aging. Some of his more remarkable lines of research interest: Arterial Spin Labeling in dementia, fMRI for objective olfactory function appraisal in neurological disorders and neurodegeneration, and multidimensional neuroimaging biomarkers for automatic aid diagnosis.